Compare Danaher Corporation (DHR) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Snap Inc — how do they compare? Danaher Corporation trades at $200.49 (market cap $140.88B), while Snap Inc trades at $4.77 (market cap $7.87B). The key difference: Danaher Corporation is far larger — about 17.9× Snap Inc's market cap, and Danaher Corporation pays a 0.8% dividend while Snap Inc pays none. Which is the better fit depends on your goals.
| DHR | SNAP | |
|---|---|---|
Market Cap | $140.88B | $7.87B |
Sector | Health | Media |
52-Week High | $242.05 | $10.35 |
52-Week Low | $161.91 | $3.93 |
Enterprise Value | $153.66B | $9.25B |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
Snap Inc. (SNAP) trades at $4.665, down 0.32% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $5.93B in 2025, with a net loss of $460.49M, though losses have narrowed year-over-year. Recent news highlights the launch of high-priced AR glasses, which has drawn investor skepticism and contributed to stock volatility.
The outlook remains cautious; while cost-cutting and revenue growth offer potential, persistent losses, high debt, and competitive pressures pose significant risks. Analyst consensus is mixed with a $6.82 price target, suggesting moderate upside if execution improves, but the stock faces headwinds from weak profitability and market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
